Silencing of SARS‐CoV‐2 with modified siRNA‐peptide dendrimer formulation

Clinical characteristics of 140 patients infected with SARS‐CoV‐2 in Wuhan, China

(2020) Jin-jin Zhang et al.   ALLERGY

Immune response to SARS‐CoV‐2 and mechanisms of immunopathological changes in COVID‐19

(2020) Ahmet Kursat Azkur et al.   ALLERGY

Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform

(2020) Tran Thi Nhu Thao et al.   NATURE

Remdesivir for the Treatment of Covid-19 — Preliminary Report

(2020) John H. Beigel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Covid-19: FDA approves use of convalescent plasma to treat critically ill patients

(2020) Janice Hopkins Tanne   BMJ-British Medical Journal

The hallmarks of COVID-19 disease

(2020) Daolin Tang et al.   PLoS Pathogens

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

(2020) Xin Zou et al.   Frontiers of Medicine

Computational Identification of Small Interfering RNA Targets in SARS-CoV-2

(2020) Wei Chen et al.   VIROLOGICA SINICA

COVID-19: The first documented coronavirus pandemic in history

(2020) Yen-Chin Liu et al.   Biomedical Journal

Antibodies in serum of convalescent patients following mild COVID-19 do not always prevent virus receptor binding

(2020) Pia Gattinger et al.   ALLERGY

The Origin of COVID-19 and Why It Matters

(2020) David M. Morens et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Phase 1/2 study of COVID-19 RNA vaccine BNT162b1 in adults

(2020) Mark J. Mulligan et al.   NATURE

Clinical efficacy of antivirals against novel coronavirus (COVID-19): A review

(2020) Shahamah Jomah et al.   Journal of Infection and Public Health

Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia

(2020) Denis Y Logunov et al.   LANCET

SARS-CoV-2 vaccines in development

(2020) Florian Krammer   NATURE

Animal models for COVID-19

(2020) César Muñoz-Fontela et al.   NATURE

Ad26 vaccine protects against SARS-CoV-2 severe clinical disease in hamsters

(2020) Lisa H. Tostanoski et al.   NATURE MEDICINE

Convalescent plasma treatment of severe COVID-19: a propensity score–matched control study

(2020) Sean T. H. Liu et al.   NATURE MEDICINE

REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters

(2020) Alina Baum et al.   SCIENCE

Mechanisms of SARS-CoV-2 transmission and pathogenesis

(2020) Andrew G. Harrison et al.   TRENDS IN IMMUNOLOGY

Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial

(2020) Maheshi N Ramasamy et al.   LANCET

REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19

(2020) David M. Weinreich et al.   NEW ENGLAND JOURNAL OF MEDICINE

Respiratory syncytial virus upregulates IL-33 expression in mouse model of virus-induced inflammation exacerbation in OVA-sensitized mice and in asthmatic subjects

(2020) Alexandra Nikonova et al.   CYTOKINE

Clinical advances of siRNA therapeutics

(2019) Bo Hu et al.   JOURNAL OF GENE MEDICINE

Dendrimers as Pharmaceutical Excipients: Synthesis, Properties, Toxicity and Biomedical Applications

(2019) Ana Santos et al.   Materials

RNA Secondary Structure Motifs of the Influenza A Virus as Targets for siRNA-Mediated RNA Interference

(2019) Julita Piasecka et al.   Molecular Therapy-Nucleic Acids

RNA Interference as a Prospective Tool for the Control of Human Viral Infections

(2018) Alesia Levanova et al.   Frontiers in Microbiology

RNA Interference-Induced Innate Immunity, Off-Target Effect, or Immune Adjuvant?

(2017) Zhongji Meng et al.   Frontiers in Immunology

Aerosol Delivery of siRNA to the Lungs. Part 1: Rationale for Gene Delivery Systems

(2016) Susanne R. Youngren-Ortiz et al.   KONA Powder and Particle Journal

Designed cell penetrating peptide dendrimers efficiently internalize cargo into cells

(2014) Gabriela A. Eggimann et al.   CHEMICAL COMMUNICATIONS

Small Interfering RNAs Targeted to Interleukin-4 and Respiratory Syncytial Virus Reduce Airway Inflammation in a Mouse Model of Virus-Induced Asthma Exacerbation

(2014) Musa R. Khaitov et al.   HUMAN GENE THERAPY

Dendrimers as Carriers for siRNA Delivery and Gene Silencing: A Review

(2013) Jiangyu Wu et al.   TheScientificWorldJOURNAL

Water-soluble N-[(2-hydroxy-3-trimethylammonium)propyl]chitosan chloride as a nucleic acids vector for cell transfection

(2012) Evgeny Faizuloev et al.   CARBOHYDRATE POLYMERS

Pulmonary delivery of therapeutic siRNA

(2011) Jenny Ka-Wing Lam et al.   ADVANCED DRUG DELIVERY REVIEWS

Peptide dendrimers as efficient and biocompatible gene delivery vectors: Synthesis and in vitro characterization

(2010) Kui Luo et al.   JOURNAL OF CONTROLLED RELEASE

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application

(2009) Aimee L. Jackson et al.   NATURE REVIEWS DRUG DISCOVERY

Emerging infections: a perpetual challenge

(2008) David M Morens et al.   LANCET INFECTIOUS DISEASES

Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

(2008) Mark E. Kleinman et al.   NATURE